Steven A. Kaplan, MD

Icahn School of Medicine at Mount Sinai

Steven A. Kaplan, M.D., FACS
Professor of Urology
Director, The Men's Health Program

Steven Kaplan graduated from Mount Sinai School of Medicine in 1982 and was elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included residency in Urology at Columbia University. He was an American Urologic Association Scholar between 1988 – 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction.

Dr. Kaplan was the Given Foundation Professor of Urology and Vice Chairman of the Department of Urology at Columbia University from 1998 – 2005. He is currently Professor of Urology and Director of The Men's Health Program at the Icahn School of Medicine at Mount Sinai and Chair of Research of the American Urological Association.

Dr. Kaplan is a serial entrepreneur and a founder of Medidata Solutions Inc., a publicly held corporation and one of the premier electronic data capture companies in the world; Medivizor, Inc., a medical informatics enterprise; Eco – Fusion, a novel health care interface platform and InspiReN, a digital interface analyzing and enhancing the patient experience with health care professionals.

Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is a recognized authority on the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has published more than 1200 articles, 170 abstracts, and has made over 340 presentations in more than 35 countries. He is the co - author of five books and is on the Editorial Board of Urology, Journal of Urology, and Urology Times. Dr. Kaplan has been a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over 13 million dollars in research funding.

Disclosure information not submitted.

Presentation(s):

• AUA Office of Research Update

  Thursday, May 12, 2022
  8:35 AM – 8:42 AM

• 024IC - New AUA BPH Guidelines: How to Best Diagnose and How to Most Effectively and Safely Treat

  Saturday, May 14, 2022
  7:30 AM – 9:30 AM

• MP29-09: Aquablation: Multi-Pass Impact

  Saturday, May 14, 2022
  1:00 PM – 2:15 PM

• BPH

  Saturday, May 14, 2022
  3:10 PM – 3:30 PM

• Developing a Personalized BPH Strategy

  Sunday, May 15, 2022
  10:45 AM – 11:05 AM

• PD45: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology IV

  Sunday, May 15, 2022
  1:00 PM – 3:00 PM

• PD45-05: Functional Improvement and Preservation of Sexual Function 3 Years After Treatment with the Optilume BPH Catheter System

  Sunday, May 15, 2022
  1:40 PM – 1:50 PM

• Diagnostics

  Monday, May 16, 2022
  7:31 AM – 7:45 AM

• Panel with Case Discussion

  Monday, May 16, 2022
  8:15 AM – 8:30 AM